Filtered By:
Specialty: Endocrinology
Condition: Diabetes

This page shows you your search results in order of relevance. This is page number 18.

Order by Relevance | Date

Total 1416 results found since Jan 2013.

Effects of GLP-1 receptor agonists on neurological complications of diabetes
AbstractEmerging evidence suggests that treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) could be an interesting treatment strategy to reduce neurological complications such as stroke, cognitive impairment, and peripheral neuropathy. We performed a systematic review to examine the evidence concerning the effects of GLP-1 RAs on neurological complications of diabetes. The databases used were Pubmed, Scopus and Cochrane. We selected clinical trials which analysed the effect of GLP-1 RAs on stroke, cognitive impairment, and peripheral neuropathy. We found a total of 19 studies: 8 studies include stroke or ...
Source: Reviews in Endocrine and Metabolic Disorders - May 26, 2023 Category: Endocrinology Source Type: research

Predicting Macro- and Microvascular Complications in Type 2 Diabetes: The Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine.
CONCLUSIONSThe risk engine accurately predicts macro- and microvascular complications and would provide helpful information in risk classification and health economic simulations. PMID: 23404305 [PubMed - as supplied by publisher]
Source: Diabetes Care - February 12, 2013 Category: Endocrinology Authors: Tanaka S, Tanaka S, Iimuro S, Yamashita H, Katayama S, Akanuma Y, Yamada N, Araki A, Ito H, Sone H, Ohashi Y, for the Japan Diabetes Complications Study Group, the Japanese Elderly Diabetes Intervention Trial Group Tags: Diabetes Care Source Type: research

Diabetes and end-stage renal disease synergistically contribute to increased incidence of cardiovascular events: A nation-wide follow-up study during 1998-2009.
ConclusionsDiabetes and ESRD synergistically increase risks of CV events. Proactive screening and control for diabetes in patients with ESRD should be built into our daily practice. PMID: 23920086 [PubMed - as supplied by publisher]
Source: Diabetes Care - August 6, 2013 Category: Endocrinology Authors: Chang YT, Wu JL, Hsu CC, Wang JD, Sung JM Tags: Diabetes Care Source Type: research

Intensity of peri-operative glycemic control and postoperative outcomes in patients with diabetes: a meta-analysis
Conclusions: Pooled results suggest that in patients with diabetes, a moderate peri-operative glycemic target (150–200mg/dl [5.6–8.3mmol/l]) is associated with reduction in postoperative mortality and stroke compared with a liberal target (>200mg/dl [11.1mmol/l]), whereas no significant additional benefit was found with more strict glycemic control (
Source: Diabetes Research and Clinical Practice - June 10, 2013 Category: Endocrinology Authors: Bharath Sathya, Rebecca Davis, Tracey Taveira, Hilary Whitlatch, Wen-Chih Wu Tags: Reviews Source Type: research

Associations of blood glucose and prevalent diabetes with risk of cardiovascular disease in 500 000 adult Chinese: the China Kadoorie Biobank
ConclusionsIn the present adult Chinese population, self‐reported diabetes was associated with a doubling of the odds of prevalent cardiovascular disease. Below the threshold for diabetes there was still a modest, positive association between random blood glucose and prevalent cardiovascular disease.This article is protected by copyright. All rights reserved.
Source: Diabetic Medicine - December 17, 2013 Category: Endocrinology Authors: F. Bragg, L. Li, M. Smith, Y. Guo, Y. Chen, I. Millwood, Z. Bian, R. Walters, J. Chen, L. Yang, R. Collins, R. Peto, Y. Lu, B. Yu, X. Xie, Y. Lei, G. Luo, Z. Chen, Tags: Research Article Source Type: research

Role of Comorbidities as Limiting Factors to the Effect of Hyperbaric Oxygen in Diabetic Foot Patients: A Retrospective Analysis
Conclusions Diabetic foot patients with histories of coronary artery diseases or stroke and non-proliferative or proliferative retinopathy might resist HBOT. PAD at the femoral arterial level has been shown to have a significant negative effect on HBOT outcomes that should be first considered for surgery. In contrast, PAD below the knee does not seem to be an obstacle to the efficacy of HBOT.
Source: Diabetes Therapy - October 2, 2014 Category: Endocrinology Source Type: research

The role of triglyceride in cardiovascular disease in asian patients with type 2 diabetes--a systematic review.
Authors: Chen AH, Tseng CH Abstract In Asian populations, diabetes mellitus is increasing and has become an important health problem in recent decades. Cardiovascular disease (CVD) is one of the most important complications and the most common cause of death in diabetic patients. Among the risk factors of CVD, elevated low-density lipoprotein cholesterol has been a major concern. Studies suggested that serum triglyceride may also play a role in predicting CVD in patients with type 2 diabetes mellitus, but the association is still debated. In this review, we summarized published studies focusing on the relationship ...
Source: Review of Diabetic Studies - November 19, 2014 Category: Endocrinology Tags: Rev Diabet Stud Source Type: research

Impact of diabetes‐related complications on healthcare costs: new results from the UK Prospective Diabetes Study
ConclusionsDiabetic complications are associated with substantial immediate and long‐term healthcare costs. Our comprehensive new estimates of these costs, derived from detailed recent UK Prospective Diabetes Study post‐trial data, should aid researchers and health policy analyses.This article is protected by copyright. All rights reserved.
Source: Diabetic Medicine - November 29, 2014 Category: Endocrinology Authors: M. L. Alva, A. Gray, B. Mihaylova, J. Leal, R. R. Holman Tags: Research Article Source Type: research

The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84)
ConclusionsDiabetic complications are associated with substantial immediate and long‐term healthcare costs. Our comprehensive new estimates of these costs, derived from detailed recent UK Prospective Diabetes Study post‐trial data, should aid researchers and health policy analyses.This article is protected by copyright. All rights reserved.
Source: Diabetic Medicine - November 29, 2014 Category: Endocrinology Authors: M. L. Alva, A. Gray, B. Mihaylova, J. Leal, R. R. Holman Tags: Research Article Source Type: research

Subclinical hypothyroidism and the associations with macrovascular complications and chronic kidney disease in patients with Type 2 diabetes
ConclusionsThis study provides evidence that SCH in patients with Type 2 diabetes is associated with a high prevalence of CHD (and CKD in severe SCH), although not with ischaemic stroke.This article is protected by copyright. All rights reserved.
Source: Diabetic Medicine - February 12, 2015 Category: Endocrinology Authors: Fang Jia, Jing Tian, Fuxue Deng, Gangyi Yang, Min Long, Wei Cheng, Bo Wang, Jinlin Wu, Dongfang Liu Tags: Research Article Source Type: research

Impact of age-adjusted Insulin-like Growth Factor I on major cardiovascular events after acute myocardial infarction.
CONCLUSIONS: Low IGF-I score is associated with increased risk of all cause-death, recurrent MI and stroke in AMI patients. Whether patients treated by IGF-I axis inhibitors have a specific clinical course after AMI would be worth studying. PMID: 25699636 [PubMed - as supplied by publisher]
Source: The Journal of Clinical Endocrinology and Metabolism - February 20, 2015 Category: Endocrinology Authors: Bourron O, Le Bouc Y, Berard L, Kotti S, Brunel N, Ritz B, Leclercq F, Tabone X, Drouet E, Mulak G, Danchin N, Simon T Tags: J Clin Endocrinol Metab Source Type: research

Is diabetes a hypercoagulable state? A critical appraisal
Abstract Diabetes mellitus (DM), a chronic disease with an increasing incidence and prevalence worldwide, is an established risk factor for arterial cardiovascular, cerebrovascular and peripheral vascular diseases including acute myocardial infarction, stroke and peripheral artery disease. On the other hand, its role as independent risk factor for venous thromboembolism (VTE) and for cardioembolic stroke or systemic embolism (SE) in patients with atrial fibrillation (AF) is more conflicting. Venous and arterial thromboses have traditionally been regarded as separate diseases, but recent studies have documente...
Source: Acta Diabetologica - April 9, 2015 Category: Endocrinology Source Type: research

Association of smoking and concomitant use of metformin with cardiovascular events and mortality in people newly diagnosed with type 2 diabetes
ConclusionsIn type 2 diabetes patients, concurrent treatment with metformin attenuates the observed higher cardiovascular and mortality risk in ex‐ and current smokers. In addition to smoking cessation support, treatment with metformin, particularly in ex‐ and current smokers, should be encouraged.
Source: Journal of Diabetes - April 30, 2015 Category: Endocrinology Authors: Sanjoy K. Paul, Kerenaftali Klein, Azeem Majeed, Kamlesh Khunti Tags: Original Article Source Type: research

Cerebral Accidents in Pediatric Diabetic Ketoacidosis: Different Complications and Different Evolutions
Diabetic ketoacidosis (DKA) may be associated with neurologic complications: the most common is cerebral edema while the risk of venous and arterial stroke is rare. There is a pathogenetic link between DKA, hypercoagulability and stroke, whose risk is underestimated by clinicians. Our cases present a wide spectrum of cerebral accidents during DKA, the first one being diffuse cerebral edema, the second one venous stroke after 5 days of DKA resolution, while the third one multifocal edema suspected to be extrapontine myelinolysis although without electrolyte imbalance. Our cases suggest that DKA requires very accurate treatm...
Source: Hormone Research in Paediatrics - June 27, 2015 Category: Endocrinology Source Type: research

Earlier intensified insulin treatment of Type 1 diabetes and its association with long‐term macrovascular and renal complications
ConclusionsAll‐cause mortality, cardiovascular morbidity and progression to end‐stage renal disease did not differ in people with Type 1 diabetes earlier randomized to intensified insulin treatment.This article is protected by copyright. All rights reserved.
Source: Diabetic Medicine - August 28, 2015 Category: Endocrinology Authors: B. Rathsman, M. Donner, C. Ursing, T. Nyström Tags: Research Article Source Type: research